Interferon Therapy after Curative Surgical Intervention to Improve Prognosis in Patients with Hepatitis C-related Hepatocellular Carcinoma: a Meta-analysis

Xiang Guangming,Huang Xiaolun,Yao Yutong,Luo Le,Wang Guan,Zou Haibo
DOI: https://doi.org/10.3760/cma.j.issn.1007-8118.2016.12.004
2016-01-01
Abstract:Objective To evaluate the effects of interferon therapy after curative surgical intervention on improving prognosis of patients with hepatitis C-related hepatocellular carcinoma (HCC).Methods We searched randomized clinical trials from 1990 to 2015 on interferon therapy after curative surgical intervention in patients with hepatitis C-related HCC from the Cochrane Library,the Cochrane Database of Systematic Reviews,MEDLINE and Embase.A Meta-analysis was carried out using Revman 5.Results There were 7 studies included in this research.The results showed that interferon therapy after curative surgical intervention in patients with hepatitis C-related HCC reduced the recurrence rate of HCC at 3 years (RR =0.84,95% CI 0.73 ~0.97,P <0.05).The therapy could not improve the 3-year survival rate in these patients (RR =1.04,95% CI 0.90 ~ 1.21,P > 0.05).Stratified subgroup analyses showed interferon therapy after liver resection reduced the recurrence rate (RR =0.62,95 % CI 0.39 ~ 1.00,P =0.05).For patients with tumors less than 3 cm,interferon therapy reduced the recurrence rate (RR =0.82,95% CI 0.69 ~ 0.98,P < 0.05).Conclusion Interferon therapy after curative surgical intervention improved prognosis in patients with hepatitis C-related HCC.
What problem does this paper attempt to address?